AgingResearch.News
Genetics in Medicine

Cost-effectiveness of BRCA1/BRCA2 variant reclassification and recontact for hereditary breast and ovarian cancer in the United States

By Gregory F. Guzauskas, Sara M. Berger, Robert O’Connor, Show 6 more authorsWendy K. Chung
Figure 1 from Genetics in Medicine
Open the figure at full size
Figure 1. Guzauskas et al.
Computational studyInterventions
Paper

The paper

Gregory F. Guzauskas, Sara M. Berger, Robert O’Connor, Show 6 more authorsWendy K. Chung

University of Washington; Boston Children's Hospital

Genetics in Medicine, 26 Aug 2026

doi.org/10.1016/j.gim.2026.102697PubMed 42644306

More on Breast cancer